The UK government expects to work more closely with the PE industry as the gap between its desire for growth and ability to spur it has widened.
Investment woes in a far flung market reiterate the pressure on GPs to showcase their diligence credentials at a time when many LPs have less tolerance for risk.
Private equity managers are flocking to the secondaries market, but success in buyouts doesn’t automatically guarantee an easy ride.
There can be as many as three layers of fees in structures that give 401(k) participants exposure to private investments.
An uptick in deferred interest payments and covenant breaches could signal underlying health problems among private equity portfolios.
Firms need to demonstrate real-world returns and engage earlier with regulators and ministers, writes Gareth Davies, former UK Exchequer Secretary.
Listed alts giants have recently attempted to temper expectations when it comes to tapping US defined contribution capital – a prudent move that behoves an enormous responsibility.
Steep discounts to NAV and a slowdown in exits have likely contributed to a rash of secondaries processes involving listed PE trusts.
An explosion of hefty – and, in some cases, repeat – continuation fund processes underscores the increasing maturation of Europe’s secondaries landscape.
Though the healthcare sector’s headline deal values may look healthy enough, policy upheavals in the US and ongoing fundraising pain may be weakening its underlying condition.